Evidence for a causal role of the renin-angiotensin system in nitrate tolerance

Circulation

Volumn 99, Issue 24, 1999, Pages 3181-3187

  Kurz, Sabine ^a,b   Hink, Ulrich ^c   Nickenig, Georg ^d   Borthayre, Alain B ^a   Harrison, David G ^a   Münzel, Thomas ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Universitäts Krankhs Eppendorf ^*

Author keywords

Angiotensin; Bosentan; Chemiluminescence; Losartan; Nitric oxide; Receptors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; GLYCERYL TRINITRATE; LOSARTAN; NITRATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; ENZYME ACTIVATION; ENZYME REPRESSION; FEMALE; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033594962     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.24.3181     Document Type: Article

References (25)

1. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med. 1991;114: 667-677.
2. Packer M, Lee W, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987;317:799-804.
3. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336-2345.
4. Dupuis J, Lalonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine [see comments]. J Am Coll Cardiol. 1990;16: 923-931.
5. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95:187-194.
6. Munzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest. 1996;98:1465-1470.
7. Munzel T, Kurz S, Tarpey M, Breeman BA, Harrison DG. Similarities and discrepancies between in vivo and in vitro tolerance. Circulation. 1995;92(suppl I):I-5. Abstract.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
9. Munzel T, Bassenge E. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation. 1996;93:2052-2058.
10. Katz RJ, Levy WS, Buff L, Wasserman AG. Prevention of nitrate tolerance with angiotensin-converting enzyme inhibitors. Circulation. 1991; 83:1271-1277.
11. Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle cells. J Pharmacol Exp Ther. 1995; 271:429-437.
12. Maki S, Miyauchi T, Sakai S, Kobayashi T, Maeda S, Takata Y, Sugiyama F, Fukamizu A, Murakami K, Goto K, Sugishita Y. Endothelin-1 expression in hearts of transgenic hypertensive mice over-expressing angiotensin II. J Cardiovasc Pharmacol. 1998;31:S412-S416.
13. Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A. 1995;92:5244-5248.
14. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969;29:1349-1355.
15. Munzel T, Heitzer T, Kurz S, Harrison DG, Luhman C, Pape L, Olschewski M, Just H. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J Am Coll Cardiol. 1996;27: 297-303.
16. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Scholkens BA, Bohm M. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol. 1997;272:H2701-H2707.
17. Fishel RS, Eisenberg S, Shai SY, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension. 1995;25:343-349.
18. Stewart DJ, Holtz J, Bassenge E. Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs. Circulation. 1987;75:847-856.
19. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
20. Du ZY, Dusting GJ, Woodman OL. Effect of tolerance to glyceryl trinitrate on vascular responses in conscious rabbits. Clin Exp Pharmacol Physiol. 1991;18:439-447.
21. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72:312-318.
22. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular smooth muscle ATI receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601-609.
23. Muiesan ML, Boni E, Castellano M, Beschi M, Cefis G, Cerri B, Verdecchia P, Porcellati C, Pollavini G, Agabiti-Rosei E. Effects of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris. Eur Heart J. 1993;14: 1701-1708.
24. Mehra A, Ostrzega E, Shotan A, Johnson JV, Elkayam U. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril. Am J Cardiol. 1992;70:1310-1314.
25. Dakak N, Makhoul N, Flugelman MY, Merdier A, Shehadeh H, Schneeweiss A, Halon DA, Lewis BS. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1990;66:608-613.